Astellas Leads Pharmas, Other Japanese Manufacturers In Bottom Line
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma outpaced not only other Japanese drug makers in return on equity, it led all other major manufacturers in the country, according to a study. The Nikkei study showed drug makers in general among the top-ranking firms, led by Astellas with a 15.99 percent return. The pharmaceutical industry outranked steel makers and machinery manufacturers in success with their bottom lines. (Click here for more - a subscription may be required